3645 — Medical Net Cashflow Statement
0.000.00%
Last trade - 00:00- ¥3bn
- ¥3bn
- ¥5bn
- 64
- 36
- 38
- 42
Annual cashflow statement for Medical Net, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 104 | 254 | 539 | 251 | 153 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 10.8 | 81.4 | -80 | 142 | 159 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -57.1 | 31.5 | -146 | -26.1 | -246 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 78.3 | 392 | 343 | 429 | 120 |
| Capital Expenditures | -8.74 | -13 | -2.17 | -20.6 | -32.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -5.87 | -75 | -353 | -41.7 | -253 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -14.6 | -88 | -355 | -62.4 | -285 |
| Financing Cash Flow Items | -9.96 | — | 1.05 | 0.239 | -0.002 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -497 | -34 | 282 | -17.9 | 144 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -433 | 273 | 260 | 385 | -5.64 |